查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600207

蛋白質體學市場：按技術、設備類型、服務、應用和最終用戶分類 - 全球預測 2025-2030

Proteomics Market by Technology (Chromatography, Edman Sequencing, Electrophoresis), Instrument Type (Analytical Instruments, Reagents & Consumables, Software), Services, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023 年蛋白質體學市場價值為 317.8 億美元，預計到 2024 年將達到 360.5 億美元，預計複合年成長率為 14.67%，到 2030 年達到 829 億美元。

蛋白質體學是研究蛋白質及其結構和功能的一個廣泛領域，對於理解生物過程和機制至關重要。核心蛋白質體學研究範圍從蛋白質鑑定到交互作用分析，為個人化醫療和藥物發現的進步做出了貢獻。對蛋白質體學的需求在於它有可能闡明複雜的細胞功能並提供對疾病機制和治療性介入有效性的更深入的了解。應用範圍包括臨床診斷、生物標記發現和系統生物學，最終用途包括製藥、生物技術和學術研究。根據市場洞察，關鍵的成長要素包括質譜技術的進步、藥物發現研究活動的增加以及對個人化醫療的需求不斷成長。潛在的商機比比皆是，包括開發下一代蛋白質組學技術、擴展到開拓的新興市場以及建立策略夥伴關係以增強研發能力。為了抓住這些機會，公司應該專注於開發具有成本效益的高通量技術，同時倡導增加蛋白質體學領域的資金和合作。然而，該市場也面臨高成本、技術複雜等限制，這對更廣泛的採用構成了主要障礙。標準分散、缺乏熟練勞動力以及資料管理挑戰使成長前景更加複雜。儘管存在這些挑戰，潛在的創新領域包括蛋白質組學與基因組學和其他體學領域的整​​合、人工智慧主導的資料分析工具的開發以及提高可重複性的方法標準化等。蛋白質體學市場本質上是動態和競爭的，其特點是技術快速創新和不斷發展，因此參與者必須保持敏捷的策略來應對挑戰和滿足新興需求。為了保持競爭力，公司應繼續投資於研發，促進跨學科合作，並優先考慮以客戶為中心的方法，以滿足不斷變化的市場需求。

主要市場統計
基準年[2023] 317.8億美元
預測年份 [2024] 360.5億美元
預測年份 [2030] 829億美元
複合年成長率（%） 14.67%

市場動態：揭示快速發展的蛋白質體學市場的關鍵市場洞察

蛋白質體學市場正在因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 癌症治療的使用不斷增加以及個人化醫療的需求
    • 更多採用生物資訊學軟體和服務進行蛋白質體學研究
    • 人類蛋白質體組織和蛋白質體標準的政府計劃
  • 市場限制因素
    • 與蛋白質體資料儲存庫管理相關的高成本
  • 市場機會
    • 大量投資蛋白質體技術研發
    • 蛋白質體學生物標記發現的新投資
  • 市場挑戰
    • 蛋白質體學中胜肽鑑定的局限性

波特五力：駕馭蛋白質體學市場的策略工具

波特的五力框架是了解蛋白質體市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解蛋白質體學市場的外部影響

外部宏觀環境因素在塑造蛋白質體學市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解蛋白質體學市場的競爭格局

蛋白質體學市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣蛋白質體學市場供應商績效評估

FPNV 定位矩陣是評估蛋白質體學市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製蛋白質體學市場的成功之路

蛋白質體學市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 癌症治療的使用不斷增加以及個人化醫療的需求
      • 在蛋白質體學研究中更多地採用生物資訊學軟體和服務
      • 政府關於人類蛋白質體組織和蛋白質體標準的舉措
    • 抑制因素
      • 與蛋白質體資料儲存庫管理相關的高成本
    • 機會
      • 大量投資蛋白質體技術研發
      • 蛋白質體生物標記發現的新投資
    • 任務
      • 蛋白質體學中胜肽鑑定的局限性
  • 市場區隔分析
    • 技術：由於精度和可靠性，對層析法的需求不斷增加
    • 應用：在臨床診斷中利用蛋白質體學進行早期疾病檢測、預後與個人化治療策略
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章蛋白質體學市場：依技術分類

  • 層析法
    • 親和層析法
    • 氣相層析法
    • 離子層析法
    • 液相層析法
    • 表面層析法
  • 埃德曼序列
  • 電泳
    • 毛細管電泳
    • 凝膠電泳
  • 質譜分析
    • 傅立葉轉換質譜分析
    • 串聯式質譜法
  • 蛋白質部分
  • 蛋白質微陣列
    • 生物晶片
    • 功能蛋白微陣列
  • 表面等離子體共振
  • X光結晶結構分析

第 7 章按儀器類型分類的蛋白質體學市場

  • 分析設備
    • 層析法設備
    • 光譜儀
  • 試劑/耗材
    • 緩衝
    • 染料
  • 軟體
    • 生物資訊資料庫
    • 生物資訊學工具
    • 資料採集軟體
    • 資料分析軟體

第 8 章蛋白質體學市場：依服務分類

  • 生物資訊服務
  • 核心蛋白質體學服務

第 9 章蛋白質體學市場：依應用分類

  • 生物標記鑑定
    • 癌症生物標記
    • 心血管生物標記
  • 臨床診斷
    • 疾病診斷
    • 治療藥物監測
  • 藥物發現
    • 先導化合物的鑑定
    • 目標識別

第 10 章蛋白質體學市場：依最終使用者分類

  • 學術研究所
    • 核心研究設施
    • 大學實驗室
  • 醫院和診斷中心
    • 臨床檢驗科
    • 病理實驗室
  • 製藥公司
    • 藥品生產單位
    • 研發機構

第11章美洲蛋白質體學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太蛋白質體市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的蛋白質體學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • SPOC Proteomics 推出用於 Beta 測試的可自訂 SPOC 生物感測器，並宣布突破性 SPR 技術將改變蛋白質體學。
    • 布魯克推出 timsTOF Ultra 2，這是一款最先進的質譜儀，可透過先進的軟體整合增強單細胞蛋白質體學。
    • Biognosys 和 Alamar Biosciences 合作整合 NULISA 檢測並為 DIA-MS 平台提供支持，以進行高級蛋白質組學研究
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Applied Biomics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biognosys AG
  • Bruker Corporation
  • Cellenion SASU by Bico Group AB
  • Charles River Laboratories, Inc.
  • Creative Biolabs, Inc.
  • Creative Proteomics
  • Danaher Corporation
  • GE Healthcare
  • Illumina, Inc.
  • IsoPlexis Corporation
  • Luminex Corporation
  • Merck KGaA
  • MRM Proteomics, Inc.
  • Nautilus Biotechnology Inc.
  • NEO Proteomics, Inc.
  • Olink Holding AB
  • Perkinelmer, Inc.
  • Poochon Scientific, LLC
  • Precision Proteomics Inc.
  • Promega Corporation
  • PROMISE Proteomics
  • Proteome Sciences PLC
  • Proteomics International
  • Shantani Proteome Analytics Pvt. Ltd.
  • Thermo Fisher Scientific, Inc.
  • VProteomics
  • Waters Corporation
Product Code: MRR-434CCDA04CE5

The Proteomics Market was valued at USD 31.78 billion in 2023, expected to reach USD 36.05 billion in 2024, and is projected to grow at a CAGR of 14.67%, to USD 82.90 billion by 2030.

Proteomics, an extensive field of study of proteins, their structures, and functions, is crucial in understanding biological processes and mechanisms. At its core, the scope of proteomics extends from identifying proteins to analyzing their interactions, helping drive advances in personalized medicine and drug discovery. The necessity of proteomics lies in its potential to unravel complex cellular functions, offering deeper insights into disease mechanisms and the effectiveness of therapeutic interventions. Its applications span clinical diagnostics, biomarker discovery, and systems biology, with end-use sectors including pharmaceuticals, biotechnology, and academic research. Market insights indicate that key growth factors include advancements in mass spectrometry technology, increasing research activities in drug discovery, and rising demand for personalized medicine. Potential opportunities abound, such as developing next-generation proteomics technologies, expanding into untapped emerging markets, and forging strategic partnerships to enhance R&D capabilities. To seize these opportunities, businesses should focus on developing cost-effective and high-throughput technologies while simultaneously advocating for increased funding and collaboration in the proteomics field. However, the market also faces limitations, such as the high cost of instruments and technical complexity, which pose significant barriers to broader adoption. Fragmentation in standardization, lack of skilled personnel, and data management challenges further complicate growth prospects. Despite these challenges, promising areas for innovation include integrating proteomics with genomics and other omics domains, developing AI-driven data analysis tools, and enhancing method standardization to improve reproducibility. The proteomics market is inherently dynamic and competitive, characterized by rapid technological innovations and constant evolution, making it essential for players to maintain agile strategies to address challenges and meet emerging demands. To remain competitive, companies should commit to continuous investment in R&D, foster interdisciplinary collaborations, and prioritize customer-centric approaches that align with evolving market needs.

KEY MARKET STATISTICS
Base Year [2023] USD 31.78 billion
Estimated Year [2024] USD 36.05 billion
Forecast Year [2030] USD 82.90 billion
CAGR (%) 14.67%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Proteomics Market

The Proteomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing use in cancer treatment and need for personalized medicine
    • Rise in adoption of bioinformatics software & services for proteomics studies
    • Government initiatives for human proteome organization and proteomics standards
  • Market Restraints
    • High cost associated with proteomics data repository management
  • Market Opportunities
    • Significant investment in research & developments of proteomics technique
    • Emerging investments in proteomics biomarker discovery
  • Market Challenges
    • Peptide identification limitations in proteomics

Porter's Five Forces: A Strategic Tool for Navigating the Proteomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Proteomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Proteomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Proteomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Proteomics Market

A detailed market share analysis in the Proteomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Proteomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Proteomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Proteomics Market

A strategic analysis of the Proteomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Proteomics Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applied Biomics, Inc., Bio-Rad Laboratories, Inc., Biognosys AG, Bruker Corporation, Cellenion SASU by Bico Group AB, Charles River Laboratories, Inc., Creative Biolabs, Inc., Creative Proteomics, Danaher Corporation, GE Healthcare, Illumina, Inc., IsoPlexis Corporation, Luminex Corporation, Merck KGaA, MRM Proteomics, Inc., Nautilus Biotechnology Inc., NEO Proteomics, Inc., Olink Holding AB, Perkinelmer, Inc., Poochon Scientific, LLC, Precision Proteomics Inc., Promega Corporation, PROMISE Proteomics, Proteome Sciences PLC, Proteomics International, Shantani Proteome Analytics Pvt. Ltd., Thermo Fisher Scientific, Inc., VProteomics, and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Proteomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Chromatography, Edman Sequencing, Electrophoresis, Mass Spectrometry, Protein Fractionation, Protein Microarrays, Surface Plasmon Resonance, and X Ray Crystallography. The Chromatography is further studied across Affinity Chromatography, Gas Chromatography, Ion Chromatography, Liquid Chromatography, and Superficial Chromatography. The Electrophoresis is further studied across Capillary Electrophoresis and Gel Electrophoresis. The Mass Spectrometry is further studied across Fourier Transform Mass Spectrometry and Tandem Mass Spectrometry. The Protein Microarrays is further studied across Biochip and Functional Protein Microarray.
  • Based on Instrument Type, market is studied across Analytical Instruments, Reagents & Consumables, and Software. The Analytical Instruments is further studied across Chromatography Instruments and Spectrometers. The Reagents & Consumables is further studied across Buffers and Stains & Dyes. The Software is further studied across Bioinformatics Databases, Bioinformatics Tools, Data Acquisition Software, and Data Analysis Software.
  • Based on Services, market is studied across Bioinformatics Services and Core Proteomics Services.
  • Based on Application, market is studied across Biomarker Identification, Clinical Diagnostics, and Drug Discovery. The Biomarker Identification is further studied across Cancer Biomarkers and Cardiovascular Biomarkers. The Clinical Diagnostics is further studied across Disease Diagnosis and Therapeutic Drug Monitoring. The Drug Discovery is further studied across Lead Compound Identification and Target Identification.
  • Based on End User, market is studied across Academic & Research Institutes, Hospital & Diagnostic Centers, and Pharmaceutical Companies. The Academic & Research Institutes is further studied across Core Research Facilities and University Labs. The Hospital & Diagnostic Centers is further studied across Clinical Testing Departments and Pathology Labs. The Pharmaceutical Companies is further studied across Drug Manufacturing Unit and R&D Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use in cancer treatment and need for personalized medicine
      • 5.1.1.2. Rise in adoption of bioinformatics software & services for proteomics studies
      • 5.1.1.3. Government initiatives for human proteome organization and proteomics standards
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with proteomics data repository management
    • 5.1.3. Opportunities
      • 5.1.3.1. Significant investment in research & developments of proteomics technique
      • 5.1.3.2. Emerging investments in proteomics biomarker discovery
    • 5.1.4. Challenges
      • 5.1.4.1. Peptide identification limitations in proteomics
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Rising demand for chromatography due to the precision and reliability
    • 5.2.2. Application: Utilization of proteomics in clinical diagnostics for early disease detection, prognosis, and personalized treatment strategies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Proteomics Market, by Technology

  • 6.1. Introduction
  • 6.2. Chromatography
    • 6.2.1. Affinity Chromatography
    • 6.2.2. Gas Chromatography
    • 6.2.3. Ion Chromatography
    • 6.2.4. Liquid Chromatography
    • 6.2.5. Superficial Chromatography
  • 6.3. Edman Sequencing
  • 6.4. Electrophoresis
    • 6.4.1. Capillary Electrophoresis
    • 6.4.2. Gel Electrophoresis
  • 6.5. Mass Spectrometry
    • 6.5.1. Fourier Transform Mass Spectrometry
    • 6.5.2. Tandem Mass Spectrometry
  • 6.6. Protein Fractionation
  • 6.7. Protein Microarrays
    • 6.7.1. Biochip
    • 6.7.2. Functional Protein Microarray
  • 6.8. Surface Plasmon Resonance
  • 6.9. X Ray Crystallography

7. Proteomics Market, by Instrument Type

  • 7.1. Introduction
  • 7.2. Analytical Instruments
    • 7.2.1. Chromatography Instruments
    • 7.2.2. Spectrometers
  • 7.3. Reagents & Consumables
    • 7.3.1. Buffers
    • 7.3.2. Stains & Dyes
  • 7.4. Software
    • 7.4.1. Bioinformatics Databases
    • 7.4.2. Bioinformatics Tools
    • 7.4.3. Data Acquisition Software
    • 7.4.4. Data Analysis Software

8. Proteomics Market, by Services

  • 8.1. Introduction
  • 8.2. Bioinformatics Services
  • 8.3. Core Proteomics Services

9. Proteomics Market, by Application

  • 9.1. Introduction
  • 9.2. Biomarker Identification
    • 9.2.1. Cancer Biomarkers
    • 9.2.2. Cardiovascular Biomarkers
  • 9.3. Clinical Diagnostics
    • 9.3.1. Disease Diagnosis
    • 9.3.2. Therapeutic Drug Monitoring
  • 9.4. Drug Discovery
    • 9.4.1. Lead Compound Identification
    • 9.4.2. Target Identification

10. Proteomics Market, by End User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
    • 10.2.1. Core Research Facilities
    • 10.2.2. University Labs
  • 10.3. Hospital & Diagnostic Centers
    • 10.3.1. Clinical Testing Departments
    • 10.3.2. Pathology Labs
  • 10.4. Pharmaceutical Companies
    • 10.4.1. Drug Manufacturing Unit
    • 10.4.2. R&D Laboratories

11. Americas Proteomics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Proteomics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Proteomics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. SPOC Proteomics launched customizable SPOC biosensors for beta testing, announcing breakthrough SPR technology set to transform proteomics
    • 14.3.2. Bruker launched timsTOF Ultra 2, a state-of-the-art mass spectrometry device enhancing single-cell proteomics with advanced software integration
    • 14.3.3. Biognosys and Alamar Biosciences partner to integrate NULISA assays and enhance DIA-MS platform for advanced proteomics research
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Applied Biomics, Inc.
  • 3. Bio-Rad Laboratories, Inc.
  • 4. Biognosys AG
  • 5. Bruker Corporation
  • 6. Cellenion SASU by Bico Group AB
  • 7. Charles River Laboratories, Inc.
  • 8. Creative Biolabs, Inc.
  • 9. Creative Proteomics
  • 10. Danaher Corporation
  • 11. GE Healthcare
  • 12. Illumina, Inc.
  • 13. IsoPlexis Corporation
  • 14. Luminex Corporation
  • 15. Merck KGaA
  • 16. MRM Proteomics, Inc.
  • 17. Nautilus Biotechnology Inc.
  • 18. NEO Proteomics, Inc.
  • 19. Olink Holding AB
  • 20. Perkinelmer, Inc.
  • 21. Poochon Scientific, LLC
  • 22. Precision Proteomics Inc.
  • 23. Promega Corporation
  • 24. PROMISE Proteomics
  • 25. Proteome Sciences PLC
  • 26. Proteomics International
  • 27. Shantani Proteome Analytics Pvt. Ltd.
  • 28. Thermo Fisher Scientific, Inc.
  • 29. VProteomics
  • 30. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. PROTEOMICS MARKET RESEARCH PROCESS
  • FIGURE 2. PROTEOMICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PROTEOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PROTEOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PROTEOMICS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PROTEOMICS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PROTEOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PROTEOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL PROTEOMICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL PROTEOMICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES PROTEOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES PROTEOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. PROTEOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. PROTEOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PROTEOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PROTEOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PROTEOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PROTEOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PROTEOMICS MARKET DYNAMICS
  • TABLE 7. GLOBAL PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PROTEOMICS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PROTEOMICS MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PROTEOMICS MARKET SIZE, BY ION CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PROTEOMICS MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PROTEOMICS MARKET SIZE, BY SUPERFICIAL CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PROTEOMICS MARKET SIZE, BY EDMAN SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PROTEOMICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PROTEOMICS MARKET SIZE, BY GEL ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PROTEOMICS MARKET SIZE, BY FOURIER TRANSFORM MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PROTEOMICS MARKET SIZE, BY TANDEM MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PROTEOMICS MARKET SIZE, BY PROTEIN FRACTIONATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PROTEOMICS MARKET SIZE, BY BIOCHIP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PROTEOMICS MARKET SIZE, BY FUNCTIONAL PROTEIN MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PROTEOMICS MARKET SIZE, BY SURFACE PLASMON RESONANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PROTEOMICS MARKET SIZE, BY X RAY CRYSTALLOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PROTEOMICS MARKET SIZE, BY SPECTROMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL PROTEOMICS MARKET SIZE, BY BUFFERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL PROTEOMICS MARKET SIZE, BY STAINS & DYES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL PROTEOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL PROTEOMICS MARKET SIZE, BY BIOINFORMATICS DATABASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL PROTEOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL PROTEOMICS MARKET SIZE, BY DATA ACQUISITION SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL PROTEOMICS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL PROTEOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL PROTEOMICS MARKET SIZE, BY CORE PROTEOMICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL PROTEOMICS MARKET SIZE, BY CANCER BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL PROTEOMICS MARKET SIZE, BY CARDIOVASCULAR BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL PROTEOMICS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL PROTEOMICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL PROTEOMICS MARKET SIZE, BY LEAD COMPOUND IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL PROTEOMICS MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL PROTEOMICS MARKET SIZE, BY CORE RESEARCH FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL PROTEOMICS MARKET SIZE, BY UNIVERSITY LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL PROTEOMICS MARKET SIZE, BY CLINICAL TESTING DEPARTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 69. GLOBAL PROTEOMICS MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 70. GLOBAL PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 71. GLOBAL PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 72. GLOBAL PROTEOMICS MARKET SIZE, BY DRUG MANUFACTURING UNIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 73. GLOBAL PROTEOMICS MARKET SIZE, BY R&D LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 74. GLOBAL PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 79. AMERICAS PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 80. AMERICAS PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. AMERICAS PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 82. AMERICAS PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 83. AMERICAS PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 84. AMERICAS PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 85. AMERICAS PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. AMERICAS PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 87. AMERICAS PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 88. AMERICAS PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 89. AMERICAS PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. AMERICAS PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 91. AMERICAS PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 92. AMERICAS PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 93. AMERICAS PROTEOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 94. ARGENTINA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. ARGENTINA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 96. ARGENTINA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 97. ARGENTINA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 98. ARGENTINA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 99. ARGENTINA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ARGENTINA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 101. ARGENTINA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 102. ARGENTINA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 103. ARGENTINA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 104. ARGENTINA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ARGENTINA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ARGENTINA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 107. ARGENTINA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 108. ARGENTINA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. ARGENTINA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 110. ARGENTINA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 111. ARGENTINA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 112. BRAZIL PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. BRAZIL PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 114. BRAZIL PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 115. BRAZIL PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 116. BRAZIL PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 117. BRAZIL PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. BRAZIL PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 119. BRAZIL PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 120. BRAZIL PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 121. BRAZIL PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. BRAZIL PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. BRAZIL PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 124. BRAZIL PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 125. BRAZIL PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 126. BRAZIL PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. BRAZIL PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 128. BRAZIL PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 129. BRAZIL PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 130. CANADA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. CANADA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 132. CANADA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 133. CANADA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 134. CANADA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 135. CANADA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. CANADA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 137. CANADA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 138. CANADA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 139. CANADA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 140. CANADA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. CANADA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 142. CANADA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 143. CANADA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 144. CANADA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. CANADA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 146. CANADA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 147. CANADA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 148. MEXICO PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. MEXICO PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 150. MEXICO PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 151. MEXICO PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 152. MEXICO PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 153. MEXICO PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. MEXICO PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 155. MEXICO PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 156. MEXICO PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 157. MEXICO PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 158. MEXICO PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. MEXICO PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 160. MEXICO PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 161. MEXICO PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 162. MEXICO PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. MEXICO PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 164. MEXICO PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 165. MEXICO PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 166. UNITED STATES PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. UNITED STATES PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 168. UNITED STATES PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 169. UNITED STATES PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 170. UNITED STATES PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 171. UNITED STATES PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. UNITED STATES PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 173. UNITED STATES PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 174. UNITED STATES PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 175. UNITED STATES PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 176. UNITED STATES PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. UNITED STATES PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 178. UNITED STATES PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED STATES PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED STATES PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED STATES PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED STATES PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED STATES PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED STATES PROTEOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 204. AUSTRALIA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. AUSTRALIA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 206. AUSTRALIA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 207. AUSTRALIA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 208. AUSTRALIA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 209. AUSTRALIA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. AUSTRALIA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 211. AUSTRALIA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 212. AUSTRALIA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 213. AUSTRALIA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 214. AUSTRALIA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. AUSTRALIA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 216. AUSTRALIA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 217. AUSTRALIA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 218. AUSTRALIA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. AUSTRALIA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 220. AUSTRALIA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 221. AUSTRALIA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 222. CHINA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. CHINA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 224. CHINA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 225. CHINA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 226. CHINA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 227. CHINA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. CHINA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 229. CHINA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 230. CHINA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 231. CHINA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 232. CHINA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. CHINA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 234. CHINA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 235. CHINA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 236. CHINA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. CHINA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 238. CHINA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 239. CHINA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 240. INDIA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 241. INDIA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 242. INDIA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 243. INDIA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 244. INDIA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 245. INDIA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. INDIA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 247. INDIA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 248. INDIA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 249. INDIA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 250. INDIA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. INDIA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 252. INDIA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 253. INDIA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 254. INDIA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 255. INDIA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 256. INDIA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 257. INDIA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 258. INDONESIA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 259. INDONESIA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 260. INDONESIA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 261. INDONESIA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 262. INDONESIA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 263. INDONESIA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. INDONESIA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 265. INDONESIA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 266. INDONESIA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 267. INDONESIA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 268. INDONESIA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. INDONESIA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 270. INDONESIA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 271. INDONESIA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 272. INDONESIA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 273. INDONESIA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 274. INDONESIA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 275. INDONESIA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 276. JAPAN PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 277. JAPAN PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 278. JAPAN PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 279. JAPAN PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 280. JAPAN PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 281. JAPAN PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. JAPAN PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 283. JAPAN PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 284. JAPAN PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 285. JAPAN PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 286. JAPAN PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 287. JAPAN PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 288. JAPAN PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 289. JAPAN PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 290. JAPAN PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 291. JAPAN PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 292. JAPAN PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 293. JAPAN PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 294. MALAYSIA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. MALAYSIA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 296. MALAYSIA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 297. MALAYSIA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 298. MALAYSIA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 299. MALAYSIA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. MALAYSIA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 301. MALAYSIA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 302. MALAYSIA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 303. MALAYSIA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 304. MALAYSIA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 305. MALAYSIA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 306. MALAYSIA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 307. MALAYSIA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 308. MALAYSIA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 309. MALAYSIA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 310. MALAYSIA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 311. MALAYSIA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 312. PHILIPPINES PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 313. PHILIPPINES PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 314. PHILIPPINES PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 315. PHILIPPINES PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 316. PHILIPPINES PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 317. PHILIPPINES PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. PHILIPPINES PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 319. PHILIPPINES PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 320. PHILIPPINES PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 321. PHILIPPINES PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 322. PHILIPPINES PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 323. PHILIPPINES PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 324. PHILIPPINES PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 325. PHILIPPINES PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 326. PHILIPPINES PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 327. PHILIPPINES PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 328. PHILIPPINES PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 329. PHILIPPINES PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 330. SINGAPORE PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 331. SINGAPORE PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 332. SINGAPORE PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 333. SINGAPORE PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 334. SINGAPORE PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 335. SINGAPORE PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 336. SINGAPORE PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 337. SINGAPORE PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 338. SINGAPORE PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 339. SINGAPORE PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 340. SINGAPORE PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 341. SINGAPORE PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 342. SINGAPORE PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 343. SINGAPORE PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 344. SINGAPORE PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 345. SINGAPORE PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 346. SINGAPORE PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 347. SINGAPORE PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 348. SOUTH KOREA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 349. SOUTH KOREA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 350. SOUTH KOREA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 351. SOUTH KOREA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 352. SOUTH KOREA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 353. SOUTH KOREA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 354. SOUTH KOREA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 355. SOUTH KOREA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 356. SOUTH KOREA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 357. SOUTH KOREA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 358. SOUTH KOREA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 359. SOUTH KOREA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 360. SOUTH KOREA PROTEOMICS MARKET SIZE, BY CLINIC